Toward the end of trading Monday, the Dow traded down 0.49% to 34,266.49 while the NASDAQ rose 0.72% to 14,463.26. The S&P also rose, gaining 0.05% to 4,283.04.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,625,390 cases with around 603,960 deaths. India confirmed a total of at least 30,279,330 cases and 396,730 deaths, while Brazil reported over 18,420,590 COVID-19 cases with 513,470 deaths. In total, there were at least 181,167,050 cases of COVID-19 worldwide with more than 3,924,860 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Information technology shares jumped by 1% on Monday. Meanwhile, top gainers in the sector included QAD Inc. QADB, up 79%, and JinkoSolar Holding Co., Ltd. JKS, up 22%.
In trading on Monday, energy shares fell 3.2%.
Top Headline
Perion Network Ltd PERI reported preliminary second-quarter FY21 revenue growth of 74% year-on-year to $105 million, exceeding the consensus of $95.86 million.
Perion Network raised the FY21 revenue guidance from the previous $390 million - $410 million to $410 million- $430 million. The Adjusted EBITDA outlook increased from $39 million - $41 million to $49 million $51 million.
Equities Trading UP
Intellia Therapeutics, Inc. NTLA shares shot up 50% to $133.00 after the company announced positive clinical data for its CRISPR therapy.
Shares of QAD Inc. QADB got a boost, shooting 79% to $86.09 after the company announced it will be acquired by Thoma Bravo for $2 billion, or $87.50 per share in cash.
New Senior Investment Group Inc. SNR shares were also up, gaining 29% to $8.90. Ventas announced plans to acquire New Senior Investment Group in a transaction valued at $2.3 billion.
Check out these big movers of the day
Equities Trading DOWN
CEL-SCI Corporation CVM shares tumbled 48% to $12.96. CEL-SCI announced results from its Phase 3 study for its immunotherapy Multikine for advanced previously untreated squamous cell carcinoma of the head and neck (SCCHN).
Shares of Kiromic BioPharma, Inc. KRBP were down 24% to $7.58. Kiromic Biopharma announced the company will be presenting at 2021 Next-Gen Immuno Oncology Congress showcasing its proprietary AI targets for off-the-shelf allogenic CAR-T for solid tumors.
Exelixis, Inc. EXEL was down, falling 23% to $17.96 after the company provided a data update on its Phase 3 trial in patients with previously untreated advanced liver cancer.
Commodities
In commodity news, oil traded down 1.5% to $72.92, while gold traded up 0.1% to $1,779.40.
Silver traded up 0.5% Monday to $26.21 while copper fell 0.5% to $4.2725.
Euro zone
European shares closed lower today. The eurozone’s STOXX 600 slipped 0.59%, the Spanish Ibex Index fell 1.99% and the German DAX 30 fell 0.34%. Meanwhile, the London’s FTSE 100 fell 0.88%, French CAC 40 dropped 0.98% and Italy’s FTSE MIB declined 1.11%.
Import prices in Germany increased 11.8% year-over-year in May versus a 10.3% surge in the earlier month .
Economics
The Dallas Fed manufacturing index for June is scheduled for release at 10:30 a.m. ET. After a strong 34.9 reading in May, analysts expect the index retreating to 32.5 in June.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
